Branford, CT February 15, 2021 / Enrich Therapeutics Inc. announced today that the company signed a lease for 5,500 square feet of independent lab and office space in Business Park of Branford, CT. It is currently setting up its new operation space and will be completely moving out of BioCT Incubator in Groton by the end of this month. This new expansion would greatly benefit the company’s team building, business operation, collaborating R&D projects, as well as investor relationships.
About Enrich Therapeutics Inc.:
Enrich Therapeutics is a privately held company, founded in July 2018, focused on the development of novel single cell isolation platform along with the critical life science applications. Enrich Therapeutics aims to enhance global biomedical research at true single cell level with superior affordability and strength. Its static cell capture technology enables clone isolation under desired micro-environment with real-time monitoring. Enrich technology is making extensive impact in fields of basic biology, CAR-T, antibody, tumor genetics, etc., and is committed to isolating single clones from any physiologically relevant scenario. Additional information about the company may be found at www.enrichtx.com.
For more information: